Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Response to two consecutive protease inhibitor combination therapy regimens in a cohort of HIV-1-infected children.

Palacios GC, Palafox VL, Alvarez-Muñoz MT, Vazquez G, Miranda G, Muñoz O, Solorzano F.

Scand J Infect Dis. 2002;34(1):41-4.

PMID:
11874163
2.

Anti-retroviral therapy for HIV-infected children--toward maximal effectiveness.

Melvin AJ.

Pediatr Infect Dis J. 1999 Aug;18(8):723-4. Review.

PMID:
10462343
3.

Boosted protease inhibitors as a therapeutic option in the treatment of HIV-infected children.

Ramos J.

HIV Med. 2009 Oct;10(9):536-47. doi: 10.1111/j.1468-1293.2009.00728.x. Review.

4.

[Anti-retroviral treatment of HIV infection in the child].

De José Gómez MI.

Allergol Immunopathol (Madr). 1998 May-Jun;26(3):139-44. Review. Spanish.

PMID:
9675397
5.

What we know so far.

Gazzard B.

AIDS. 1996 Nov;10 Suppl 1:S3-7. Review.

PMID:
8970669
6.

Simplification: is it sufficient?

Cartledge JD.

HIV Med. 2000;1 Suppl 1:3-6. Review. No abstract available.

7.

Role of viral load blips, drug boosting, and therapeutic holidays in HIV patient management.

Bean P.

Am Clin Lab. 2001 Sep;20(8):11-3. Review. No abstract available.

PMID:
11586932
8.

Early experience with protease inhibitors in human immunodeficiency virus-infected children.

Sáez-Llorens X, Ramilo O.

Pediatr Infect Dis J. 1998 Aug;17(8):728-38. Review. No abstract available.

PMID:
9726349

Supplemental Content

Support Center